TORONTO, Nov. 8, 2022
/CNW/ - Invesque Inc. (TSX: IVQ.U) (TSX: IVQ) (the "Company") today
announced its results for the three and nine months ended
September 30, 2022.
Third Quarter 2022 and Subsequent Highlights
- The Company continued to execute on its previously announced
disposition strategy in the third quarter of 2022, committed to
becoming primarily focused on private-pay seniors housing assets.
To date this year, the Company has sold US$218 million of assets. In the third quarter,
the Company announced the following sale transactions:
-
- On July 26, 2022, closed on the
sale of a medical office building in Orlando, Florida for US$9.85 million. The sale price reflected the
high quality of the underlying real estate equal to nearly
US$300 per rentable square
foot(1) and a 7.2% capitalization rate(2) on
trailing net operating income ("NOI").
- On July 28, 2022, closed on the
sale of the majority of its medical office buildings in
Canada for US$73.6 million. The pricing was equal to
US$207 per rentable square
foot(1) and represented a 5.0% capitalization
rate(2) on trailing NOI.
- On August 30, 2022, closed on the
sale of two skilled nursing facilities in Nebraska to the former operator, Hillcrest
Health Services. The US$25 million
sale price reflected the high quality of the underlying real estate
and represented a price per bed of US$168
thousand(3) which compares favorably to the
average price per bed for skilled nursing facilities.
- Subsequent to quarter end, the Company continued to execute on
its strategic plan to sell its remaining medical office
buildings.
-
- On October 28, 2022, the Company
signed an agreement to sell Brantford Medical Center in
Brantford, ON, for approximately
US$5.8 million, which transaction is
expected to close in November.
- Potential purchasers for the three remaining medical
office buildings in the US are being identified, and sale
transactions are likely to occur in the first half of 2023.
- Reported funds from operations ("FFO") of US$0.12 and US$0.30
per common share for the three and nine months ending September 30, 2022. The Company reported adjusted
funds from operations ("AFFO") of US$0.11 and US$0.29
per common share for the three and nine months ending September 30, 2022.
"I am very pleased with the sale transactions we've completed
over the last 18 months and continue to be excited about where we
are headed." said Scott White,
Chairman & Chief Executive Officer of the Company. "Our efforts
are now focused on our private pay seniors housing portfolio. We
continue to see occupancy and overall financial improvements across
our Commonwealth and other senior housing portfolios, and we expect
that to continue in the fourth quarter and into 2023."
1. Price
per rentable square foot is a non-GAAP supplementary financial
measure. This metric is computed by dividing the transactional sale
price of the asset by the rentable square footage of the
property.
2. The capitalization rate on transactions is a
non-GAAP supplementary financial measures. This metric is an
implied percentage, computed by dividing the trailing 12-month net
operating income of the property by the transactional sale price of
the asset.
3. Price per bed is a non-GAAP supplementary financial
measure. This metric is computed by dividing the transaction sale
price of the asset by the number of rentable beds of the
property.
|
Financial Highlights
|
Three months ended
September 30,
|
|
Nine months ended
September 30,
|
(in thousands of U.S
dollars, except per share values)
|
2022
|
2021
|
|
2022
|
2021
|
|
|
|
|
|
|
Revenue
|
$
49,665
|
$
49,373
|
|
$
147,991
|
$
148,296
|
Net income
(loss)
|
$
(13,503)
|
$
(5,082)
|
|
$
(17,845)
|
$
(6,782)
|
FFO
(1)
|
$
6,725
|
$
5,643
|
|
$
17,087
|
$
20,750
|
FFO per
share
|
$
0.12
|
$
0.10
|
|
$
0.30
|
$
0.37
|
AFFO
(1)
|
$
6,207
|
$
4,766
|
|
$
16,460
|
$
19,729
|
AFFO per
share
|
$
0.11
|
$
0.08
|
|
$
0.29
|
$
0.35
|
|
|
|
|
|
|
(1) FFO and AFFO
are measures used by management to evaluate operating
performance. Please refer to the section "Non-IFRS Measures"
in this press release for more information.
|
Balance Sheet and Portfolio Highlights
(in thousands of U.S.
dollars, except number of properties)
|
September 30,
2022
|
|
December 31,
2021
|
|
|
|
|
Total assets
|
1,124,453
|
|
1,301,011
|
Number of
properties
|
77
(1)
|
|
102
(2)
|
Debt
|
760,048
|
|
893,746
|
|
|
|
|
(1) Excludes four
medical office buildings held for sale as of September 30,
2022.
|
(2) Excludes one
asset held for sale as of December 31, 2021.
|
Investor Conference Call
A conference call hosted by the Company's senior management team
will be held on November 9, 2022, at
10:00 AM EST. The telephone numbers
for the conference call are Local: (647) 794-4605, or Toll-Free:
(888) 204-4368. The passcode for the conference call is 7563760.
The conference will also be available via webcast at
https://www.invesque.com/company-presentations/. Please log on at
least 15 minutes before the call commences. The telephone numbers
to listen to the call after it is completed (taped replay) are
Local: (416) 764-8677, or Toll Free: (888) 390-0541. The Passcode
for the taped replay is 578410#.
About Invesque
The Company is a North American health care real estate company
with an investment thesis focused on the premise that an aging
demographic in North America will
continue to utilize health care services in growing proportion to
the overall economy. The Company currently capitalizes on this
opportunity by investing in a portfolio of income-generating
properties across the health care spectrum. The Company's portfolio
includes investments in independent living, assisted living, memory
care, skilled nursing, transitional care, and medical office
properties, which are operated under long-term leases and joint
venture arrangements with industry-leading operating partners. The
Company's portfolio also includes investments in owner-occupied
seniors housing properties in which the Company owns the real
estate and provides management services through Commonwealth Senior
Living, LLC, a Delaware limited
liability company ("Commonwealth").
Forward-Looking Information
This press release (this "Press Release") contains certain
forward-looking information and/or statements ("forward-looking
statements"), that reflect and are provided for the purpose of
presenting information about management's current expectations and
plans relating to the future, including, without limitation,
statements regarding the Company's utilization of proceeds of
dispositions and statements regarding the closing of the sale of
certain of the Company's medical office buildings. Forward-looking
information is typically identified by terms such as "anticipate,"
"believe," "continue," "expect," "expectations," "look," "may,"
"plan," "project," "should," "will," and other similar expressions
that do not relate solely to historical matters and suggest future
outcomes or events. Readers should not place undue reliance
on forward-looking statements and are cautioned that
forward-looking statements may not be appropriate for other
purposes. Forward-looking statements in this Press Release are
based on current beliefs, expectations, and certain assumptions of
the Company's management, including that any conditions relating to
the sale of the Company's medical office buildings will be
satisfied or waived and such transactions will be completed when
currently expected. Forward-looking statements in this Press
Release are subject to significant known and unknown risks,
uncertainties, and other factors that are beyond the Company's
ability to predict or control, including the risk that the sale of
one or more of the Company's medical office buildings will not
close due to the inability to satisfy closing conditions, and may
cause actual results or events to differ materially from those
expressed or implied by such statements and, accordingly, should
not be read as guarantees of future performance or results and will
not necessarily be accurate indications of whether or not such
results will be achieved. The Company's actual results may differ
as a result of various factors, including without limitation, the
negative impact of COVID-19 pandemic on the Company's business and
the business of operators/tenants, including without limitation,
uncertainty regarding the duration and severity thereof and
negative economic conditions arising therefrom, uncertainty
regarding implementation and impact of existing and future stimulus
and other Covid-19 relief legislation, laws, orders, and guidance
throughout the United States and
Canada may be available to
operators/tenants to offset the costs and conditions related
thereto, and the extent to which support may terminate upon
termination of any federally declared public health emergency, the
negative effect of travel bans and restrictions, stay-at-home
orders, social distancing guidelines, limitations on other business
activities, staffing shortages, increased costs, and the impact on
occupancy rates in our communities in connection therewith, rent
deferral rates, the ability of operators/tenants to comply with
infection control and vaccine protocols, and the long-term impact
of vaccines on facility infection rates; the status of the economy;
the status of capital markets, including, without limitation,
availability and cost of capital; issues facing the health care
industry, including, without limitation, compliance with, and
changes to, regulations and payment policies, responding to
government investigations and settlements and operators'/tenants'
ability to cost effectively obtaining and maintaining adequate
liability and other insurance; the risk that the Company's
operators/tenants and borrowers may become subject to bankruptcy or
insolvency proceedings; changes in financing terms; competition
throughout the health care and senior housing industries; the
operating results or financial condition of operators/tenants,
including, without limitation, their ability to pay rent and repay
loans, the Company's ability to transition, buy, or sell properties
with profitable results as and when anticipated, and occupancy
levels; the effect of other factors affecting the Company's
business and facilities outside of the Company's or
operators'/tenants control, including without limitation, natural
disasters, other health crises or pandemics, governmental action,
particularly in the healthcare industry, protests, strikes, and
shortages in supply chains, as well as the risks described in the
Company's current annual information form and management's
discussion and analysis, available on SEDAR at www.sedar.com, which
risks may be dependent on market factors and not entirely within
the Company's control. Although management believes that it has a
reasonable basis for the expectations reflected in these
forward-looking statements, actual results may differ from those
suggested by the forward-looking statements for various reasons.
These forward-looking statements reflect current expectations of
the Company as of the date of this Press Release and speak only as
of the date of this Press Release. The Company does not undertake
any obligation to publicly update or revise any forward-looking
statements except as may be required by applicable law.
There can be no assurance that forward-looking statements will
prove to be accurate as actual outcomes and results may differ
materially from those expressed in these forward-looking
statements. Readers are cautioned not to place undue reliance on
any such forward-looking statements, which are given as of the date
hereof, and not to use such forward-looking statements for anything
other than the intended purpose. Further, except as expressly
required by applicable law, the Company assumes no obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events, or otherwise.
Forward-looking statements contained in this Press Release are
expressly qualified by this cautionary statement.
Non-IFRS Measures
The Company reports its financial results in accordance with
International Financial Reporting Standard ("IFRS"). Included in
this Press Release are certain non-IFRS financial measures as
supplemental indicators used by the Company's management to track
the Company's performance. These non-IFRS measures are NOI, FFO,
and AFFO. The Company believes that these non-IFRS financial
measures provide useful information to both the Company's
management and investors in measuring the financial performance and
financial condition of the Company. These measures do not have a
standardized meaning prescribed by IFRS and, therefore, may not be
comparable to similar measures presented by other companies, nor
should they be construed as an alternative to other financial
measures determined in accordance with IFRS. For a full
definition of these measures, please refer to the Financial
Measures section of the September 30, 2022, MD&A available
on the Company's website and on SEDAR at www.sedar.com, which
information is incorporated herein by reference, and the full
reconciliation to which are included below.
FFO Tables
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|
2022
|
2021
|
2022
|
2021
|
Net loss from
continuing operations for the period
|
$
(12,449)
|
$
(4,180)
|
$
(16,017)
|
$
(6,633)
|
Add/(deduct):
|
|
|
|
|
Change in fair value of
investment properties
|
13,966
|
11,626
|
35,433
|
9,550
|
Property taxes
accounted for under IFRIC 21
|
(2,827)
|
(2,253)
|
2,824
|
3,952
|
Depreciation and
amortization expense
|
3,838
|
4,700
|
11,315
|
18,068
|
Amortization of tenant
inducements
|
61
|
75
|
182
|
225
|
Accretion expense and
amortization of non-cash adjustments to the 2016 Convertible
Debentures
|
635
|
—
|
2,204
|
—
|
Change in fair value of
financial instruments
|
(6,463)
|
(1,922)
|
(23,150)
|
(7,582)
|
Change in fair value of
contingent consideration
|
—
|
(192)
|
—
|
1,005
|
Loss on sale of
property, plant and equipment
|
3,670
|
(40)
|
3,009
|
(54)
|
Deferred income tax
recovery
|
—
|
—
|
(1,127)
|
—
|
Allowance for credit
losses on loans and interest receivable
|
6,752
|
(19)
|
7,222
|
666
|
Change in
non-controlling interest liability in respect of the
above
|
(38)
|
(105)
|
60
|
(345)
|
Adjustments for equity
accounted entities
|
(295)
|
(2,567)
|
(5,428)
|
416
|
|
|
|
|
|
FFO from continuing
operations
|
$
6,850
|
$
5,123
|
$
16,527
|
$
19,268
|
FFO from discontinued
operations
|
(125)
|
520
|
560
|
1,482
|
|
|
|
|
|
Total FFO
|
$
6,725
|
$
5,643
|
$
17,087
|
$
20,750
|
Weighted average number
of shares, including fully vested deferred shares: Basic
|
56,626,021
|
56,363,180
|
56,684,212
|
56,278,776
|
|
|
|
|
|
Funds from operations
per share
|
$
0.12
|
$
0.10
|
$
0.30
|
$
0.37
|
AFFO Tables
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|
2022
|
2021
|
2022
|
2021
|
Cash flows provided by
(used in) operating activities
|
$
6,168
|
$
3,386
|
$
14,287
|
$
11,318
|
Change in non-cash
working capital
|
(719)
|
2,097
|
2,074
|
6,944
|
Less: interest expense
(1)
|
(9,655)
|
(10,331)
|
(29,116)
|
(34,050)
|
Less: change in
non-controlling interest liability
|
(72)
|
225
|
(448)
|
271
|
Plus: loss from joint
ventures
|
221
|
1,569
|
4,146
|
(100)
|
Plus: interest
paid
|
11,412
|
11,193
|
31,483
|
36,007
|
Less: interest
received
|
(144)
|
(153)
|
(414)
|
(523)
|
Plus: debt
extinguishment costs
|
(10)
|
213
|
584
|
945
|
Plus: transaction costs
for business combination
|
—
|
—
|
—
|
—
|
Plus: non-cash portion
of non-controlling interest expense
|
(42)
|
(108)
|
49
|
(490)
|
Plus: adjustments for
equity accounted entities
|
(286)
|
(1,576)
|
(4,373)
|
1,280
|
Plus: deferred share
incentive plan compensation
|
63
|
(918)
|
376
|
620
|
Plus: write-off of
deferred financing costs from refinancing
|
—
|
—
|
—
|
—
|
Less: capital
maintenance reserve
|
(729)
|
(831)
|
(2,188)
|
(2,493)
|
|
|
|
|
|
AFFO
|
$
6,207
|
$
4,766
|
$
16,460
|
$
19,729
|
Weighted average number
of shares, including fully vested deferred shares: Basic
|
56,626,021
|
56,363,180
|
56,684,212
|
56,235,874
|
|
|
|
|
|
Funds from operations
per share
|
$
0.11
|
$
0.08
|
$
0.29
|
$
0.35
|
SOURCE Invesque Inc.